Amgen Inc (AMGN)

Exchange
NASDAQ
Symbol
AMGN
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Country
USA

Stock price

At close: November 20, 2024

  • Open
    281.10
  • High
    288.48
  • Low
    278.56
  • Close
    287.87
  • Volume
    4,759,330

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
1.88
Receivables turnover
3.27
Payables turnover
11.26
Working capital turnover
2.18
Days of inventory on hand (DOH)
194.11
Days of sales outstanding (DSO)
111.60
Number of days of payables
32.43
Fixed asset turnover
4.37
Total asset turnover
0.27
 Liquidity ratios
Current ratio
1.65
Quick ratio
1.27
Cash ratio
0.84
Cash conversion cycle
273.28
 Solvency ratios
Debt-to-assets ratio
0.65
Debt-to-capital ratio
0.91
Debt-to-equity ratio
10.14
Financial leverage ratio
15.59
Interest coverage
2.75
 Profitability ratios
Gross profit margin
31.10%
Operating profit margin
30.40%
Pretax margin
30.24%
Net profit margin
25.86%
Operating return on assets (Operating ROA)
8.13%
Return on assets (ROA)
6.91%
Return on total capital
11.38%
Return on equity (ROE)
107.78%